European Archives - Page 892 of 898 - European Medical Journal

Continue
October 2013

EMJ Cardiology 2013

Welcome to the inaugural edition of the European Medical Journal – Diabetes, which hosts in depth commentary from the 49th Annual Meeting of the European…
17th October 2013

Ace-Inhibitors and Cardioprotection Open Issues and Future Solutions

The current management of patients with hypertension, especially those with a high risk of coronary artery disease should take into account the role of…
17th October 2013

The Changing Landscape in Oral Anticoagulation - The Last Pieces of the Puzzle

Dabigatran, rivaroxaban, apixaban and edoxaban are four new oral anticoagulants (NOACs). There are an increasing number of indications for which these…
17th October 2013

Practical Guidance for Stroke Prevention in Atrial Fibrillation – Interactive Case Studies

This Boehringer Ingelheim sponsored satellite symposium was held on 2nd September 2013 as part of the ESC conference, which was hosted this year in…
17th October 2013

Managing Thromboembolic Risks of Atrial Fibrillation: Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices?

Ischaemic/embolic complications are the most common severe consequences of atrial fibrillation. Although chronic anticoagulation with warfarin has been…
17th October 2013

Atrial Fibrillation in Childhood with Familial Hyperthyroidism in Afro-Caribbeans

Atrial fibrillation (AF) associated with familial hyperthyroidism (FH) spanning three generations concomitantly, is rare. The index case was 10 years old…
17th October 2013

Consistency Versus Equity – Cardiovascular Disease Management For South Asians in the United Kingdom

An increased risk of coronary heart disease was an immediate healthcare concern following the mass arrival of South Asian immigrants to the UK, and it…
17th October 2013

Prescribing Physical Activity for the Prevention and Treatment of Hypertension in Patients with Aortic Coarctation - A Review

Patients who have been treated for aortic coarctation (CoA) have increased late cardiovascular morbidity and mortality, which is partly due to the…
17th October 2013

Initial Evidence in Thromboangiitis Obliterans (Buerger’s Disease) Treatment with Bosentan

Thromboangiitis obliterans (TAO) is a vascular disease that affects small and medium-sized arteries and veins of both upper and lower extremities. Distal…
17th October 2013

Nationwide Family Studies of Cardiovascular Diseases - Clinical and Genetic Implications of Family History

Studies of family history (FH) have long been used to estimate the heritability of cardiovascular diseases (CVDs). Genome-wide association studies (GWAS)…